The ups and downs of elevator-type di-/tricarboxylate membrane transporters.
The ups and downs of elevator-type di-/tricarboxylate membrane transporters.
复制标题
DOI:
10.1111/febs.16158
复制
发表时间:
2022-03
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
The divalent anion sodium symporter (DASS) family contains both sodium-driven anion co-transporters and anion/anion exchangers. The family belongs to a broader Ion Transporter Superfamily (ITS), which comprises 24 families of transporters, including those of AbgT antibiotic efflux transporters. The human proteins in the DASS family play major physiological roles and are drug targets. We recently determined multiple structures of the human sodium-dependent citrate transporter (NaCT) and the succinate/dicarboxylate transporter from Lactobacillus acidophilus (LaINDY). Structures of both proteins show high degrees of structural similarity to the previously-determined VcINDY fold. Conservation between these DASS protein structures and those from the AbgT familiy indicates that the VcINDY fold represents the overall protein structure for the entire ITS superfamily. The new structures of NaCT and LaINDY are captured in the inward- or outward-facing conformations, respectively. The domain arrangements in these structures agree with a rigid-body elevator-type transport mechanism for substrate translocation across the membrane. Two separate NaCT structures in complex with a substrate or an inhibitor allowed us to explain the inhibition mechanism and propose a detailed classification scheme for grouping disease-causing mutations in the human protein. Structural understanding of multiple kinetic states of DASS proteins is a first step towards the detailed characterization of their entire transport cycle. Liver cells import citrate as an energy source and a precursor for fatty acid synthesis. This uptake is accomplished via the Na+-driven citrate transporter (NaCT) in the plasma membrane. Inhibition of uptake can reduce fat storage. We determined the structure of human NaCT in complex with an inhibitor. The structure reveals how the compound inhibits transport and why it inhibits NaCT selectively over other homologous dicarboxylate transporters in humans.
登录
查看更多内容
DOI:
10.1152/ajpgi.00371.2006
发表时间:
2007-01-01
影响因子:
4.5
作者:
Gopal, Elangovan;Miyauchi, Seiji;Ganapathy, Vadivel
通讯作者:
Ganapathy, Vadivel
影响因子:
4.1
作者:
FANG, M;LOWENSTEIN, JM
通讯作者:
LOWENSTEIN, JM
影响因子:
5.6
作者:
Lolkema, JS;Slotboom, DJ
通讯作者:
Slotboom, DJ
影响因子:
4.1
作者:
Inoue, K;Fei, YJ;Ganapathy, V
通讯作者:
Ganapathy, V
影响因子:
4.8
作者:
Inoue, K;Zhuang, L;Ganapathy, V
通讯作者:
Ganapathy, V